… been implicated as causal factors for obesity in patients.However, neurologic or … patient
obesity witnessed by physicians for the past 30 years. Recent increases in the rate of obesity …

… regarding outcomes of patients with MO and … obesity is protective in patients with heart
failure, both MO and heart failure markedly reduce functional capacity.Anecdotally, patients with …

… outcome and safety of gastric balloon therapy (GBT) in extremely obese … safety and
efficacy of GBT in extremely obese patients particularly as a first step before a definitive anti-obesity …

Objective This study aimed to evaluate ertugliflozin in patients with overweight and obesity
with type 2 diabetes mellitus. Methods Data from three placebo‐controlled, randomized, …

… related to the safety and efficacy of the bariatric surgery, our choice of matched noncirrhotic,
obese controls is appropriate. However, the 1-year outcomes in a patient with compensated …

… orlistat in the treatment of obesity and related conditions in both adults and adolescents were
recently reviewed (16–18). In addition to obesity, the efficacy and safety of both drugs in the …

… to suggest tailored treatment plans for their patients. In this review, we aimed to provide
an overview of the efficacy and safety of anti-obesity drugs that manages long-term obesity. …

… On the basis of these and other data, an assessment was made that the overall safety and
efficacy profile of taranabant did not support its further development for the treatment of obesity…

… efficacy of antiobesity drugs, this article reviews all long-term (≥36 weeks), placebo-controlled
trials of obesity … preclude many physicians and patients from even considering antiobesity …

… of all available literature worldwide to assess the effectiveness and safety of ESG in >1800
patients. Our analysis shows that ESG is safe and effective in the treatment of obesity. …